TORONTO, Jan. 25 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX:
ARI), a biotechnology company discovering and developing the next wave of
antibody therapeutics, today announced it will hold a conference call to
discuss its fourth quarter and year end 2007 results at 8:00 a.m. (Eastern
Time) on Tuesday, January 29, 2008. The Company will report its results in
a press release to be issued at 7:00 a.m. prior to the call.
DATE: Tuesday, January 29, 2008
TIME: 8:00 a.m., Eastern Standard Time
WEBCAST: A live audio webcast of the call will be available at
http://www.ariusmabs.com. Webcast attendees are welcome to listen to the
conference in real-time or on-demand at their convenience. The webcast will
be archived for 365 days. Please connect to this website at least 15
minutes prior to the conference call to ensure adequate time for any
software download that may be needed to hear the webcast.
TAPED REPLAY: 416-644-3414 or 1-800-731-6941 (Available until
February 5, 2008)
REFERENCE NUMBER: 21261080
ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST(TM), that rapidly identifies and selects antibodies based on their functional ability to affect disease. This antibody generation engine has enabled ARIUS to assemble a portfolio of more than 500 antibody candidates. In addition to the antibodies it is developing in-house, ARIUS has ongoing partnerships with key biotechnology and drug development companies. ARIUS is listed on the TSX under the symbol "ARI". For further information, visit http://www.ariusmabs.com
Certain statements in this news release constitute
|SOURCE ARIUS Research Inc.|
Copyright©2008 PR Newswire.
All rights reserved